Investors
Agios is a biopharmaceutical company passionately committed to applying our scientific leadership in the field of cellular metabolism to transform the lives of patients with cancer and rare genetic diseases.
Stock is 

Quarterly Results

Show all
Q4 2019 Earnings
Q3 2019 Earnings
Q2 2019 Earnings
Q1 2019 Earnings
Q4 2018 Earnings
Q3 2018 Earnings
Q2 2018 Earnings
Q1 2018 Earnings
Q4 2017 Earnings
Q3 2017 Earnings
Q2 2017 Earnings
Q1 2017 Earnings
Q4 2016 Earnings
Q3 2016 Earnings
Q2 2016 Earnings
Q1 2016 Earnings
Q4 2015 Earnings
Q3 2015 Earnings
Q2 2015 Earnings
Resources
FAQs
Email Alerts
Publications